| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »


Results 1 - 1 out of 1 displayed.
Search filter:
  • Search for: Company
Sort direction:
Sort direction:
 |   |   | 
Carlsbad, California, USA
Main sector:
  • Biotechnology - Therapeutics and Diagnostics
  • Anti-infectives
  • Nucleic acid drugs
  • Cardiovascular / cardiology
  • Congenital malformations, deformations and chromosomal abnormalities / medical genetics
  • Digestive system / gastroenterology
  • Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
  • Diseases of the eye / ophthalmology
  • Diseases of the nervous system / neurology
  • Endocrine, nutritional and metabolic diseases / endocrinology
  • Genitourinary system / Urology
  • Infectious and parasitic diseases / infectiology / parasitology
  • Musculoskeletal system and connective tissue / Orthopedics
  • Neoplasms / cancer / oncology
  • Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
  • Worldwide: 927
  • In development: 26
  • On the market: 6
Ionis Pharmaceuticals is a biotechnology company that specializes in discovering and developing RNA-targeted therapeutics. The company currently has five marketed medicines and a pipeline (10+ in mid- or late-stage development) in neurology, cardiology, and other areas. Ionis’ proprietary antisense technology that targets RNA is the basis of drug discovery to treat diseases with a focus on neurology and cardiometabolic diseases. Antisense therapies are designed to seek out, bind to and destroy...

Already have a valid Biotechgate account? Login here »

Get access to Biotechgate

Download complete company profiles including product pipelines, financing rounds and management details.

to the top ↑